Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Robert Huizinga

Tracked across 4 events · 26 articles · First seen May 29, 2026 · Last active Sep 09, 2026

Sentiment
2
Attention
2
Events
4
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
1 0
Business
Kane Biotech Inc., a biotechnology company focused on microbial biofilms and wound care, announced on September 9, 2026, that it will host a virtual Commercial Update webcast on September 16, 2026. The webcast will feature…
Impact: Dr. Robert Huizinga, Interim CEO, will present operational and commercial updates, outlining the company's execution priorities.
Sep 09, 2026 · 6 articles
2 0
Business
Impact: Robert Huizinga is the Interim CEO of Kane Biotech and is among the recipients of the stock options.
May 29, 2026 · 6 articles
1 10
Business
Impact: As Interim CEO, Robert Huizinga is focused on executing commercial objectives while evaluating strategic initiatives, playing a key role in the review process.
Aug 05, 2026 · 7 articles
1 0
Tech
Impact: Dr. Robert Huizinga, Interim CEO, commented on the interest generated, representing the company's leadership in this development.
Aug 25, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Robert Huizinga live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.